REG - Animalcare Group PLC - PDMR Dealing – Dividend Reinvestment Plan

AnimalcareAnnouncement

05/10/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231005:nRSE7368Oa&default-theme=true

RNS Number : 7368O  Animalcare Group PLC  05 October 2023

 ANIMALCARE GROUP PLC

(the "Company")

PDMR DEALING - DIVIDEND REINVESTMENT PLAN

 

5 October 2023. Animalcare Group plc (AIM: ANCR), the international animal
health business, confirms that it has received notification that Marc Coucke,
a Non-Executive Director of the Company, has acquired 192,700 Ordinary Shares
in the Company pursuant to a dividend reinvestment plan ("DRIP").

 

Following the acquisition, Mr Coucke has an interest in 14,751,674 Ordinary
Shares representing approximately 24.55% of the Company's total issued share
capital.

 

The following disclosures are made in accordance with the UK Market Abuse
Regulation.

 

 1    Details of the person discharging managerial responsibilities / person closely
      associated
 -

 a)   Name                                      Marc Coucke, Non-Executive Director

 2    Reason for the notification

 a)   Position/status                           See 1(a) above - Mr Coucke is classified as a PDMR of the Company

 b)   Initial notification                      Initial Notification

      /Amendment

 3    Details of the issuer, emission allowance market participant, auction
      platform, auctioneer or auction monitor

 a)   Name                                      Animalcare Group plc

 b)   LEI                                       213800A7XPQ528RMCC72

 4    Details of the transaction(s): section to be repeated for (i) each type of
      instrument; (ii) each type of transaction; (iii) each date; and (iv) each
      place where transactions have been conducted

 a)   Description of the financial instrument, type of instrument   Ordinary shares of 20p each ("Shares")

 b)   Identification code                                           GB0032350695
                                                                    Acquisition of Shares pursuant to a DRIP

 c)   Nature of the transaction(s)

 d)   Price(s) and volume(s)                                        Volume(s):

                                                                    192,700

                                                                    Price:

                                                                    £1.81

 e)   Aggregated information                                        N/A Single transaction

      - Aggregated volume

      - Price

 f)   Date of the transaction                                       24 July 2023

 g)   Place of the transaction                                      London Stock Exchange

 

 

Enquiries:

 Animalcare Group plc
 Chris Brewster, Chief Financial Officer and Company Secretary  +44 (0)1904 487 687

                                                                communications@animalcaregroup.com
 Stifel Nicolaus Europe Limited                                 +44 (0)20 7710 7600

 (Nominated Adviser & Joint Broker)
 Ben Maddison

 Nick Adams

 Nick Harland

 Francis North
 Panmure Gordon                                                 +44 (0)20 7886 2500

 (Joint Broker)
 Corporate Finance:

 Freddy Crossley/Emma Earl

 Corporate Broking:

 Rupert Dearden

About Animalcare www.animalcaregroup.com (http://www.animalcaregroup.com/)

Animalcare Group plc is a UK AIM-listed international veterinary sales and
marketing organisation. Animalcare operates in seven countries and exports to
approximately 40 countries in Europe and worldwide. The Group is focused on
bringing new and innovative products to market through its own development
pipeline, partnerships and via acquisition.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHUSOBROSURRAA